10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IXHL (Incannex) Stock Analysis
Buy, Hold or Sell?

Let's analyze Incannex together

I guess you are interested in Incannex Healthcare Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Incannex’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Incannex’s Price Targets

I'm going to help you getting a better view of Incannex Healthcare Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Incannex Healthcare Ltd ADR

I send you an email if I find something interesting about Incannex Healthcare Ltd ADR.

1. Quick Overview

1.1. Quick analysis of Incannex (30 sec.)










1.2. What can you expect buying and holding a share of Incannex? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.05
Expected worth in 1 year
$0.00
How sure are you?
45.0%

+ What do you gain per year?

Total Gains per Share
$-0.05
Return On Investment
-22.6%

For what price can you sell your share?

Current Price per Share
$0.21
Expected price per share
$0.08 - $0.471
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Incannex (5 min.)




Live pricePrice per Share (EOD)
$0.21
Intrinsic Value Per Share
$-1.33 - $-0.67
Total Value Per Share
$-1.28 - $-0.62

2.2. Growth of Incannex (5 min.)




Is Incannex growing?

Current yearPrevious yearGrowGrow %
How rich?$4.8m$28.4m-$24.1m-560.1%

How much money is Incannex making?

Current yearPrevious yearGrowGrow %
Making money-$3.5m$3.1m-$6.7m-189.3%
Net Profit Margin-27,570.7%-17.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Incannex (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Incannex?

Welcome investor! Incannex's management wants to use your money to grow the business. In return you get a share of Incannex.

First you should know what it really means to hold a share of Incannex. And how you can make/lose money.

Speculation

The Price per Share of Incannex is $0.2089. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Incannex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Incannex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.05. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Incannex.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.03-13.3%-0.04-18.3%-0.03-14.9%-0.03-16.4%-0.02-11.2%-0.02-7.5%
Usd Book Value Change Per Share0.0521.6%-0.01-5.7%0.014.3%0.001.3%0.001.1%0.000.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0521.6%-0.01-5.7%0.014.3%0.001.3%0.001.1%0.000.6%
Usd Price Per Share0.68-1.93-2.24-1.67-1.11-0.56-
Price to Earnings Ratio-6.07--12.03--17.37--11.92--9.93--4.97-
Price-to-Total Gains Ratio14.97--60.81--31.62--33.04--44.61--44.61-
Price to Book Ratio13.02-101.52-18.17-41.43-30.85-15.42-
Price-to-Total Gains Ratio14.97--60.81--31.62--33.04--44.61--44.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2089
Number of shares4786
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (4786 shares)-56.6011.11
Gains per Year (4786 shares)-226.4044.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-226-23604434
20-453-46208978
30-679-6880133122
40-906-9140178166
50-1132-11400222210
60-1358-13660267254
70-1585-15920311298
80-1811-18180356342
90-2038-20440400386
100-2264-22700445430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%4.069.00.05.5%
Book Value Change Per Share1.03.00.025.0%4.07.01.033.3%8.011.01.040.0%18.021.01.045.0%35.037.01.047.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.073.00.0%
Total Gains per Share1.03.00.025.0%4.07.01.033.3%8.011.01.040.0%18.021.01.045.0%35.037.01.047.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Incannex Healthcare Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.045-0.012+126%0.009+398%0.003+1551%0.002+1847%0.001+3435%
Book Value Per Share--0.0520.046+13%0.303-83%0.201-74%0.126-59%0.064-19%
Current Ratio--2.1212.113+0%7.608-72%11.086-81%13.279-84%7.543-72%
Debt To Asset Ratio--0.5430.597-9%0.109+397%0.250+117%0.193+182%0.698-22%
Debt To Equity Ratio--1.1883.412-65%0.128+830%1.195-1%0.770+54%1.230-3%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--57644454.400176675333.400-67%220926738.262-74%164179780.064-65%206365029.090-72%206365029.090-72%
Eps---0.028-0.038+37%-0.031+12%-0.034+23%-0.023-16%-0.016-44%
Ev To Ebitda Ratio---5.709-11.979+110%-24.186+324%-15.012+163%-19.816+247%-19.816+247%
Free Cash Flow Per Share---0.022-0.023+5%-0.016-27%-0.022+0%-0.015-32%-0.011-51%
Free Cash Flow To Equity Per Share--0.032-0.003+108%-0.016+151%0.006+415%0.008+297%0.003+1139%
Gross Profit Margin--1.0001.0040%1.010-1%1.056-5%1.123-11%1.198-17%
Intrinsic Value_10Y_max---0.672----------
Intrinsic Value_10Y_min---1.329----------
Intrinsic Value_1Y_max---0.047----------
Intrinsic Value_1Y_min---0.097----------
Intrinsic Value_3Y_max---0.156----------
Intrinsic Value_3Y_min---0.324----------
Intrinsic Value_5Y_max---0.285----------
Intrinsic Value_5Y_min---0.586----------
Market Cap19572969.060-224%63431785.800180996088.950-65%210184548.435-70%156164465.565-59%129036127.339-51%64518063.670-2%
Net Profit Margin----275.7070%-0.1790%-143.7630%-89.1940%-116.6730%
Operating Margin----272.2010%-0.1960%-139.3280%-86.0860%-61.3240%
Operating Ratio---330.420-100%1.220-100%163.522-100%100.830-100%68.999-100%
Pb Ratio4.018-224%13.020101.518-87%18.165-28%41.432-69%30.847-58%15.424-16%
Pe Ratio-1.874+69%-6.073-12.035+98%-17.372+186%-11.922+96%-9.933+64%-4.966-18%
Price Per Share0.209-224%0.6771.932-65%2.243-70%1.667-59%1.115-39%0.557+21%
Price To Free Cash Flow Ratio-2.354+69%-7.628-21.607+183%-1077.403+14024%-369.263+4741%-225.130+2851%-112.565+1376%
Price To Total Gains Ratio4.620-224%14.971-60.809+506%-31.616+311%-33.039+321%-44.609+398%-44.609+398%
Quick Ratio---0.796-100%7.356-100%10.557-100%12.903-100%7.234-100%
Return On Assets---0.245-0.373+52%-0.060-75%-0.233-5%-0.388+58%-2.616+968%
Return On Equity---0.536-2.010+275%-0.086-84%-0.792+48%-0.767+43%-0.721+35%
Total Gains Per Share--0.045-0.012+126%0.009+398%0.003+1551%0.002+1847%0.001+3435%
Usd Book Value--4871914.3004307264.500+13%28434267.902-83%18840631.200-74%12814888.470-62%6489898.259-25%
Usd Book Value Change Per Share--0.045-0.012+126%0.009+398%0.003+1551%0.002+1847%0.001+3435%
Usd Book Value Per Share--0.0520.046+13%0.303-83%0.201-74%0.126-59%0.064-19%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--57644454.400176675333.400-67%220926738.262-74%164179780.064-65%206365029.090-72%206365029.090-72%
Usd Eps---0.028-0.038+37%-0.031+12%-0.034+23%-0.023-16%-0.016-44%
Usd Free Cash Flow---2078937.900-2177981.950+5%-1524141.173-27%-2081601.409+0%-1724069.298-17%-1177714.632-43%
Usd Free Cash Flow Per Share---0.022-0.023+5%-0.016-27%-0.022+0%-0.015-32%-0.011-51%
Usd Free Cash Flow To Equity Per Share--0.032-0.003+108%-0.016+151%0.006+415%0.008+297%0.003+1139%
Usd Market Cap19572969.060-224%63431785.800180996088.950-65%210184548.435-70%156164465.565-59%129036127.339-51%64518063.670-2%
Usd Price Per Share0.209-224%0.6771.932-65%2.243-70%1.667-59%1.115-39%0.557+21%
Usd Profit---2611340.800-3577267.075+37%3194071.606-182%-1815761.942-30%-1668124.495-36%-1220683.359-53%
Usd Revenue---16123.450-100%166808.442-100%76148.161-100%138149.380-100%89158.717-100%
Usd Total Gains Per Share--0.045-0.012+126%0.009+398%0.003+1551%0.002+1847%0.001+3435%
 EOD+2 -6MRQTTM+25 -10YOY+13 -223Y+18 -175Y+13 -2210Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of Incannex Healthcare Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.874
Price to Book Ratio (EOD)Between0-14.018
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.121
Debt to Asset Ratio (MRQ)Less than10.543
Debt to Equity Ratio (MRQ)Less than11.188
Return on Equity (MRQ)Greater than0.15-0.536
Return on Assets (MRQ)Greater than0.05-0.245
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Incannex Healthcare Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.212
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Incannex Healthcare Ltd ADR

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-06-24 15:12:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Incannex earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27,570.7%+27,570.7%
TTM-27,570.7%YOY-17.9%-27,552.8%
TTM-27,570.7%5Y-8,919.4%-18,651.3%
5Y-8,919.4%10Y-11,667.3%+2,747.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Incannex is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -24.5% Return on Assets means thatΒ Incannex generatedΒ $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Incannex Healthcare Ltd ADR:

  • The MRQ is -24.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.5%TTM-37.3%+12.8%
TTM-37.3%YOY-6.0%-31.3%
TTM-37.3%5Y-38.8%+1.5%
5Y-38.8%10Y-261.6%+222.8%
4.3.1.3. Return on Equity

Shows how efficient Incannex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -53.6% Return on Equity means Incannex generated $-0.54Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Incannex Healthcare Ltd ADR:

  • The MRQ is -53.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -201.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.6%TTM-201.0%+147.4%
TTM-201.0%YOY-8.6%-192.4%
TTM-201.0%5Y-76.7%-124.3%
5Y-76.7%10Y-72.1%-4.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Incannex Healthcare Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Incannex is operatingΒ .

  • Measures how much profit Incannex makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27,220.1%+27,220.1%
TTM-27,220.1%YOY-19.6%-27,200.5%
TTM-27,220.1%5Y-8,608.6%-18,611.6%
5Y-8,608.6%10Y-6,132.4%-2,476.1%
4.3.2.2. Operating Ratio

Measures how efficient Incannex is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM330.420-330.420
TTM330.420YOY1.220+329.200
TTM330.4205Y100.830+229.590
5Y100.83010Y68.999+31.831
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Incannex Healthcare Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Incannex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.12Β means the company has $2.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 2.121. The company is able to pay all its short-term debts. +1
  • The TTM is 2.113. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.121TTM2.113+0.009
TTM2.113YOY7.608-5.495
TTM2.1135Y13.279-11.166
5Y13.27910Y7.543+5.736
4.4.3.2. Quick Ratio

Measures if Incannex is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.796-0.796
TTM0.796YOY7.356-6.561
TTM0.7965Y12.903-12.107
5Y12.90310Y7.234+5.669
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Incannex Healthcare Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of IncannexΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Incannex to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.54Β means that Incannex assets areΒ financed with 54.3% credit (debt) and the remaining percentage (100% - 54.3%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 0.543. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.597. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.543TTM0.597-0.054
TTM0.597YOY0.109+0.488
TTM0.5975Y0.193+0.404
5Y0.19310Y0.698-0.505
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Incannex is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 118.8% means that company has $1.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Incannex Healthcare Ltd ADR:

  • The MRQ is 1.188. The company is able to pay all its debts with equity. +1
  • The TTM is 3.412. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ1.188TTM3.412-2.225
TTM3.412YOY0.128+3.285
TTM3.4125Y0.770+2.642
5Y0.77010Y1.230-0.460
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Incannex generates.

  • Above 15 is considered overpriced butΒ always compareΒ Incannex to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -6.07 means the investor is paying $-6.07Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Incannex Healthcare Ltd ADR:

  • The EOD is -1.874. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.073. Based on the earnings, the company is expensive. -2
  • The TTM is -12.035. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.874MRQ-6.073+4.199
MRQ-6.073TTM-12.035+5.962
TTM-12.035YOY-17.372+5.337
TTM-12.0355Y-9.933-2.102
5Y-9.93310Y-4.966-4.966
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Incannex Healthcare Ltd ADR:

  • The EOD is -2.354. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.628. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -21.607. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.354MRQ-7.628+5.274
MRQ-7.628TTM-21.607+13.979
TTM-21.607YOY-1,077.403+1,055.796
TTM-21.6075Y-225.130+203.523
5Y-225.13010Y-112.565-112.565
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Incannex is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 13.02 means the investor is paying $13.02Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Incannex Healthcare Ltd ADR:

  • The EOD is 4.018. Based on the equity, the company is fair priced.
  • The MRQ is 13.020. Based on the equity, the company is expensive. -2
  • The TTM is 101.518. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4.018MRQ13.020-9.002
MRQ13.020TTM101.518-88.498
TTM101.518YOY18.165+83.353
TTM101.5185Y30.847+70.671
5Y30.84710Y15.424+15.424
4.6.2. Total Gains per Share

2.4. Latest News of Incannex Healthcare Ltd ADR

Does Incannex Healthcare Ltd ADR still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Incannex Healthcare Ltd ADR to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-18
13:30
Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42XRead
2025-06-17
13:30
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted TherapyRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Incannex Healthcare Ltd ADR.

4.8.1. Institutions holding Incannex Healthcare Ltd ADR

Institutions are holding 8.287% of the shares of Incannex Healthcare Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31AdvisorShares Investments, LLC0.31490.03929503412953978.2737
2025-03-31Citadel Advisors Llc0.109801028731028730
2025-03-31Morgan Stanley - Brokerage Accounts0.0533049948-6500-11.515
2025-03-31Bridgeway Capital Management, LLC0.02670.00042500000
2025-03-31Barclays PLC0.02402250200
2024-12-31UBS Group AG0.0099092556320215.3322
2025-03-31Jane Street Group LLC000-47274-100
2024-12-31Catalyst Funds Management Pty Ltd000-50-100
2024-12-31Tidal Investments LLC.000-130026-100
2024-12-31JPMorgan Chase & Co000-4-100
2025-03-31Squarepoint Ops LLC000-10702-100
2024-12-31Virtu Financial LLC000-36622-100
2024-12-31HRT FINANCIAL LLC000-23752-100
Total 0.53860.0394504612-16198-3.2%

4.9.2. Funds holding Incannex Healthcare Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-30AdvisorShares Psychedelics ETF0.36710.727234395400
2025-03-31Bridgeway Ultra-Small Company Market0.02670.01732500000
2025-04-30Fidelity Nasdaq Composite Index0.008407841-122-1.5321
2024-08-31Revisor CBD Growth Strategy0.00211.9934193819380
Total 0.40432.7379378733+1816+0.5%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Reconciled Depreciation  1130411424183-86-3
Depreciation and Amortization  1130411424183-86-3



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets16,197
Total Liabilities8,794
Total Stockholder Equity7,403
 As reported
Total Liabilities 8,794
Total Stockholder Equity+ 7,403
Total Assets = 16,197

Assets

Total Assets16,197
Total Current Assets15,629
Long-term Assets568
Total Current Assets
Cash And Cash Equivalents 6,711
Total Current Assets  (as reported)15,629
Total Current Assets  (calculated)6,711
+/- 8,918
Long-term Assets
Property Plant Equipment 568
Long-term Assets  (as reported)568
Long-term Assets  (calculated)568
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,368
Long-term Liabilities1,426
Total Stockholder Equity7,403
Total Current Liabilities
Short Long Term Debt 1,397
Accounts payable 1,039
Total Current Liabilities  (as reported)7,368
Total Current Liabilities  (calculated)2,436
+/- 4,932
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt290
Long-term Liabilities  (as reported)1,426
Long-term Liabilities  (calculated)290
+/- 1,136
Total Stockholder Equity
Total Stockholder Equity (as reported)7,403
Total Stockholder Equity (calculated)0
+/- 7,403
Other
Capital Stock2
Common Stock Shares Outstanding 19,633
Net Invested Capital 8,800
Net Working Capital 8,261
Property Plant and Equipment Gross 888



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-31
> Total Assets 
1,704
5,780
1,704
5,836
2,644
10,117
2,644
175
3,661
11,817
3,661
13,561
4,009
13,629
4,009
19,627
5,021
21,464
5,021
23,356
5,946
24,339
5,946
28,911
4,846
17,691
4,846
16,739
1,937
7,296
1,937
6,945
1,558
4,781
1,558
815
114
257
114
1,909
250
769
250
880
177
524
177
626
129
364
129
3,928
1,059
2,923
1,059
9,392
2,332
6,995
2,332
14,545
9,470
37,880
37,880
64,718
9,470
88,591
58,641
22,359
17,250
17,047
16,048
11,106
16,197
16,19711,10616,04817,04717,25022,35958,64188,5919,47064,71837,88037,8809,47014,5452,3326,9952,3329,3921,0592,9231,0593,9281293641296261775241778802507692501,9091142571148151,5584,7811,5586,9451,9377,2961,93716,7394,84617,6914,84628,9115,94624,3395,94623,3565,02121,4645,02119,6274,00913,6294,00913,5613,66111,8173,6611752,64410,1172,6445,8361,7045,7801,704
   > Total Current Assets 
1,244
4,220
1,244
3,721
317
1,214
317
72
41
132
41
394
428
1,454
428
4,460
286
1,221
286
1,394
230
942
230
3,135
516
1,883
516
1,224
115
433
115
624
1,558
4,781
1,558
802
76
85
76
1,739
210
645
210
786
135
399
135
521
96
269
96
3,847
1,059
2,923
1,059
9,392
2,332
6,995
2,332
14,545
9,470
37,880
37,880
28,636
9,470
34,686
22,960
21,332
16,319
16,202
15,209
10,504
15,629
15,62910,50415,20916,20216,31921,33222,96034,6869,47028,63637,88037,8809,47014,5452,3326,9952,3329,3921,0592,9231,0593,84796269965211353991357862106452101,7397685768021,5584,7811,5586241154331151,2245161,8835163,1352309422301,3942861,2212864,4604281,4544283944113241723171,2143173,7211,2444,2201,244
       Cash And Cash Equivalents 
1,225
4,154
1,225
3,681
282
1,081
282
43
13
42
13
301
383
1,303
383
4,228
188
802
188
1,208
139
568
139
1,959
129
470
129
1,149
99
373
99
585
44
135
44
758
62
3
62
1,374
127
390
127
519
57
169
57
227
23
66
23
3,598
901
2,487
901
9,129
2,281
6,841
2,281
14,365
9,375
37,501
37,501
28,155
9,375
33,363
22,084
14,554
9,305
5,858
3,627
2,098
6,711
6,7112,0983,6275,8589,30514,55422,08433,3639,37528,15537,50137,5019,37514,3652,2816,8412,2819,1299012,4879013,59823662322757169575191273901271,37462362758441354458599373991,1491294701291,9591395681391,2081888021884,2283831,303383301134213432821,0812823,6811,2254,1541,225
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
16
5
38
13
50
13
276
3
12
3
47
0
0
0
55
0
0
0
72
0
0
0
40
0
0
0
70
0
0
0
176
5
0
0
0
0
0
0
0
0
0000000051760007000040000720005500047312327613501338516500000000000000000000000000000000
       Net Receivables 
19
65
19
40
35
133
35
29
17
55
17
94
43
147
43
232
83
354
83
128
87
355
87
1,171
382
1,394
382
35
6
21
6
36
2
6
2
6
1
4
1
1
23
6
23
54
14
8
14
130
24
59
24
67
103
155
103
68
42
169
42
130
80
319
319
306
80
387
256
5,590
6,593
10,015
0
0
0
00010,0156,5935,59025638780306319319801304216942681031551036724592413014814542362311416262366216353821,3943821,1718735587128833548323243147439417551729351333540196519
       Other Current Assets 
0
0
0
0
0
0
0
0
11
35
11
0
1
4
1
0
9
39
9
0
1
3
1
0
2
7
2
0
0
1
0
0
1,507
4,623
1,507
0
0
34
0
0
0
75
0
37
8
57
8
0
10
37
10
50
9
155
9
31
9
154
9
51
15
60
15
482
15
1,035
1,035
6,778
7,014
10,344
0
8,406
0
08,406010,3447,0146,7781,0351,035154821560155191549319155950103710085783707500034001,5074,6231,507001002720131093990141011351100000000
   > Long-term Assets 
460
1,561
460
2,115
2,326
8,903
2,326
103
3,620
11,685
3,620
13,167
3,581
12,175
3,581
15,167
4,735
20,243
4,735
21,963
5,715
23,396
5,715
25,776
4,330
15,808
4,330
15,515
1,823
6,864
1,823
6,321
0
0
0
13
38
172
38
170
40
124
40
95
42
125
42
104
34
95
34
81
0
0
0
0
0
0
0
0
0
0
0
36,082
460
53,905
35,681
1,027
931
845
839
602
568
5686028398459311,02735,68153,90546036,082000000000008134953410442125429540124401703817238130006,3211,8236,8641,82315,5154,33015,8084,33025,7765,71523,3965,71521,9634,73520,2434,73515,1673,58112,1753,58113,1673,62011,6853,6201032,3268,9032,3262,1154601,561460
       Property Plant Equipment 
460
1,561
460
2,115
2,326
8,903
2,326
103
3,620
11,685
3,620
13,167
3,581
12,175
3,581
15,167
4,361
18,642
4,361
20,431
5,341
21,863
5,341
24,178
4,321
15,773
4,321
15,496
1,817
6,844
1,817
6,321
0
0
0
13
0
18
0
16
11
34
11
31
24
72
24
62
21
60
21
54
0
0
0
0
0
0
0
0
0
0
370
252
460
1,187
786
1,027
931
845
839
602
568
5686028398459311,0277861,1874602523700000000000542160216224722431113411160180130006,3211,8176,8441,81715,4964,32115,7734,32124,1785,34121,8635,34120,4314,36118,6424,36115,1673,58112,1753,58113,1673,62011,6853,6201032,3268,9032,3262,1154601,561460
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
154
0
154
29
90
29
64
18
53
18
42
12
35
12
27
0
0
0
0
0
0
0
0
0
0
0
35,831
29
52,717
52,717
0
0
0
0
0
0
00000052,71752,7172935,8310000000000027123512421853186429902915401540000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
43
147
43
217
261
998
261
503
1,620
5,229
1,620
7,249
561
1,909
561
3,856
803
3,433
803
4,479
570
2,335
570
7,014
760
2,775
760
4,089
1,421
5,350
1,421
4,961
1,440
4,418
1,440
673
160
780
160
678
292
898
292
586
273
808
273
402
234
656
234
273
268
740
268
292
189
566
189
398
503
2,011
2,011
884
503
4,462
2,953
3,487
3,112
5,830
9,453
10,141
8,794
8,79410,1419,4535,8303,1123,4872,9534,4625038842,0112,0115033981895661892922687402682732346562344022738082735862928982926781607801606731,4404,4181,4404,9611,4215,3501,4214,0897602,7757607,0145702,3355704,4798033,4338033,8565611,9095617,2491,6205,2291,6205032619982612174314743
   > Total Current Liabilities 
30
101
30
142
245
936
245
318
47
151
47
212
311
1,059
311
1,302
595
2,543
595
2,962
570
2,335
570
4,952
510
1,862
510
235
64
242
64
1,279
1,440
4,418
1,440
412
68
780
68
678
193
593
193
430
273
808
273
402
234
656
234
273
268
740
268
292
189
566
189
398
503
2,011
2,011
761
503
3,846
2,546
3,186
2,864
5,620
9,232
5,840
7,368
7,3685,8409,2325,6202,8643,1862,5463,8465037612,0112,01150339818956618929226874026827323465623440227380827343019359319367868780684121,4404,4181,4401,27964242642355101,8625104,9525702,3355702,9625952,5435951,3023111,05931121247151473182459362451423010130
       Short-term Debt 
0
23
0
35
0
40
0
32
0
31
0
37
217
760
217
982
0
0
0
912
237
971
237
1,039
368
1,342
368
0
0
0
0
804
0
762
0
294
0
521
0
276
0
0
0
0
50
148
50
70
16
46
16
0
0
0
0
0
0
0
0
0
0
0
0
34
217
171
113
169
161
163
0
1,737
0
01,7370163161169113171217340000000000001646167050148500000276052102940762080400003681,3423681,039237971237912000982217760217370310320400350230
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,383
1,397
1,3971,38300000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
15
50
15
92
185
706
185
286
31
101
31
175
35
118
35
320
301
1,287
301
957
44
181
44
2,823
64
235
64
195
27
103
27
441
49
151
49
118
49
106
49
402
123
412
123
396
124
366
124
307
94
264
94
200
148
407
148
292
58
175
58
398
325
1,301
1,301
727
325
2,707
1,792
1,952
1,255
527
1,496
818
1,039
1,0398181,4965271,2551,9521,7922,7073257271,3011,3013253985817558292148407148200942649430712436612439612341212340249106491184915149441271032719564235642,82344181449573011,2873013203511835175311013128618570618592155015
       Other Current Liabilities 
15
28
15
14
60
190
60
0
16
20
16
0
60
181
60
0
294
1,256
294
1,093
289
1,184
289
1,090
78
285
78
40
37
139
37
33
1,391
3,504
1,391
0
19
153
19
0
70
181
70
34
91
293
91
25
87
347
87
74
120
332
120
0
130
391
130
0
177
710
710
0
177
968
641
1,065
1,448
4,845
0
396
0
039604,8451,4481,0656419681770710710177013039113001203321207487347872591293913470181700191531901,3913,5041,3913337139374078285781,0902891,1842891,0932941,2562940601816001620160601906014152815
   > Long-term Liabilities 
13
46
13
75
16
61
16
185
1,573
5,078
1,573
7,037
250
850
250
2,554
208
890
208
1,518
371
1,485
371
2,063
250
913
250
3,854
1,356
5,108
1,356
3,682
49
1,191
49
260
92
0
92
940
99
305
99
156
182
726
182
535
147
588
147
285
148
590
148
0
58
0
58
0
325
1,301
325
123
13
616
408
301
248
210
221
4,301
1,426
1,4264,301221210248301408616131233251,3013250580580148590148285147588147535182726182156993059994092092260491,191493,6821,3565,1081,3563,8542509132502,0633711,4853711,5182088902082,5542508502507,0371,5735,0781,57318516611675134613
> Total Stockholder Equity
1,660
5,633
1,660
5,619
2,376
9,091
2,376
-328
1,662
5,365
1,662
6,313
3,069
10,433
3,069
15,771
3,847
16,444
3,847
18,877
5,004
20,484
5,004
21,897
3,480
12,702
3,480
12,650
517
1,946
517
1,984
118
363
118
143
-47
-523
-47
1,231
-42
-130
-42
294
-96
-284
-96
223
-104
-293
-104
3,655
791
2,184
791
9,100
2,143
6,429
2,143
14,147
8,967
35,869
35,869
63,834
8,967
84,129
55,688
18,872
14,138
11,217
6,595
965
7,403
7,4039656,59511,21714,13818,87255,68884,1298,96763,83435,86935,8698,96714,1472,1436,4292,1439,1007912,1847913,655-104-293-104223-96-284-96294-42-130-421,231-47-523-471431183631181,9845171,94651712,6503,48012,7023,48021,8975,00420,4845,00418,8773,84716,4443,84715,7713,06910,4333,0696,3131,6625,3651,662-3282,3769,0912,3765,6191,6605,6331,660
   Common Stock
1,974
6,699
1,974
6,929
2,847
10,894
2,847
8,461
3,065
9,895
3,065
11,830
3,857
13,112
3,857
19,779
5,296
22,642
5,296
26,163
7,107
29,092
7,107
33,007
8,514
31,080
8,514
30,374
8,514
32,064
8,514
28,311
8,675
26,616
8,675
25,307
8,689
81
8,689
15,652
5,435
16,710
5,435
18,285
6,103
18,067
6,103
18,467
6,738
18,913
6,738
23,560
8,548
23,541
8,548
34,754
11,485
34,382
11,485
45,011
21,647
86,587
86,587
102,523
21,647
150,842
99,847
2
2
2
0
2
0
02022299,847150,84221,647102,52386,58786,58721,64745,01111,48534,38211,48534,7548,54823,5418,54823,5606,73818,9136,73818,4676,10318,0676,10318,2855,43516,7105,43515,6528,689818,68925,3078,67526,6168,67528,3118,51432,0648,51430,3748,51431,0808,51433,0077,10729,0927,10726,1635,29622,6425,29619,7793,85713,1123,85711,8303,0659,8953,0658,4612,84710,8942,8476,9291,9746,6991,974
   Retained Earnings -125,953-121,984-116,091-110,671-104,210-98,179-52,143-78,774-14,699-45,758-58,795-58,795-14,699-35,701-10,170-32,912-10,170-27,322-8,130-22,442-8,130-21,111-6,955-19,531-6,955-18,539-6,256-18,520-6,256-18,169-5,519-16,966-5,519-14,540-9,604-604-9,604-27,693-9,406-28,858-9,406-29,030-8,772-33,034-8,772-20,487-5,783-21,109-5,783-14,163-2,770-11,341-2,770-9,758-1,988-8,498-1,988-5,417-871-2,962-871-6,589-1,706-5,508-1,706-9,531-755-2,890-755-1,989-480-1,629-480
   Accumulated Other Comprehensive Income 
-3
564
-3
678
-14
1,088
-14
743
-28
862
-28
988
-41
248
-41
1,409
-52
2,122
-52
2,301
-54
2,562
-54
2,836
-58
2,524
-58
2,467
-67
2,604
-67
2,431
0
2,350
0
2,237
0
0
0
0
-13
0
-13
229
-15
229
-15
0
-20
0
-20
1,663
0
1,491
0
0
0
0
0
0
0
0
0
-67,324
-3
0
12,061
-2,838
-3,658
-3,332
0
-3,407
0
0-3,4070-3,332-3,658-2,83812,0610-3-67,3240000000001,49101,663-200-200-15229-15229-130-1300002,23702,35002,431-672,604-672,467-582,524-582,836-542,562-542,301-522,122-521,409-41248-41988-28862-28743-141,088-14678-3564-3
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
169
0
169
0
299
0
299
0
332
117
332
83
125
36
125
0
590
179
590
171
722
171
722
217
806
207
806
297
842
313
842
272
849
255
849
292
868
0
868
119
54
127
54
178
72
169
72
296
133
325
133
1,206
373
1,084
373
1,668
829
4,958
829
4,838
2,019
8,077
8,077
7,069
0
12,061
-4,077
119,887
118,346
125,218
0
126,354
0
0126,3540125,218118,346119,887-4,07712,06107,0698,0778,0772,0194,8388294,9588291,6683731,0843731,206133325133296721697217854127541198680868292849255849272842313842297806207806217722171722171590179590012536125833321173320299029901690169



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue12
Cost of Revenue--
Gross Profit1212
 
Operating Income (+$)
Gross Profit12
Operating Expense-30,053
Operating Income-30,041-30,041
 
Operating Expense (+$)
Research Development12,879
Selling General Administrative16,826
Selling And Marketing Expenses348
Operating Expense30,05330,053
 
Net Interest Income (+$)
Interest Income206
Interest Expense--
Other Finance Cost-0
Net Interest Income206
 
Pretax Income (+$)
Operating Income-30,041
Net Interest Income206
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-18,429-41,653
EBIT - interestExpense = -18,607
-18,429
-18,459
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-18,607-18,429
Earnings Before Interest and Taxes (EBITDA)-18,504
 
After tax Income (+$)
Income Before Tax-18,429
Tax Provision-30
Net Income From Continuing Ops-18,459-18,459
Net Income-18,459
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses30,053
Total Other Income/Expenses Net11,612-206
 

Technical Analysis of Incannex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Incannex. The general trend of Incannex is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Incannex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Incannex Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Incannex Healthcare Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.262 < 0.31 < 0.471.

The bearish price targets are: 0.1978 > 0.17 > 0.08.

Know someone who trades $IXHL? Share this with them.πŸ‘‡

Incannex Healthcare Ltd ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Incannex Healthcare Ltd ADR. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Incannex Healthcare Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartIncannex Healthcare Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Incannex Healthcare Ltd ADR. The current adx is .

Incannex Healthcare Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Relative Strength Index (RSI) ChartIncannex Healthcare Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Stochastic Oscillator ChartIncannex Healthcare Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Commodity Channel Index (CCI) ChartIncannex Healthcare Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartIncannex Healthcare Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Williams %R ChartIncannex Healthcare Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Average True Range (ATR) ChartIncannex Healthcare Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily On-Balance Volume (OBV) ChartIncannex Healthcare Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Incannex Healthcare Ltd ADR.

Incannex Healthcare Ltd ADR Daily Money Flow Index (MFI) ChartIncannex Healthcare Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Incannex Healthcare Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Incannex Healthcare Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Incannex Healthcare Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.212
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Incannex with someone you think should read this too:
  • Are you bullish or bearish on Incannex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Incannex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Incannex Healthcare Ltd ADR

I send you an email if I find something interesting about Incannex Healthcare Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Incannex Healthcare Ltd ADR.

Receive notifications about Incannex Healthcare Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.